FindMyRecallSubscribe
Class I: serious health riskTerminated

Taro Pharmaceuticals U.S.A. Phenytoin Oral Suspension Recall

Phenytoin Oral Suspension USP, 125 mg/5 mL potency, 8 fl oz (237 mL) Rx Only Mfd

Taro Pharmaceuticals U.S.A., Inc. · Hawthorne, NY

Risk level
Class I
Reported by FDA
Mar 4, 2020
Recall ID
D-0863-2020
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals U.S.A. recalled Phenytoin Oral Suspension starting Feb 7, 2020. The FDA classified it as Class I (serious health risk) and published enforcement report D-0863-2020 on Mar 4, 2020. Reason: Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions. Status: Terminated.

Why it was recalled

Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.

Product description

Phenytoin Oral Suspension USP, 125 mg/5 mL potency, 8 fl oz (237 mL) Rx Only Mfd. by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A. Inc. Hawthorne, NY 10532, NDC 51672-4069-1

Lot numbers, UPCs & expiration codes

Lot# 327874, 327876, Exp Dec/2020

Where it was sold

Distributed Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0863-2020
Classification
Class I
Status
Terminated
Recall initiated
Feb 7, 2020
FDA report date
Mar 4, 2020
Quantity
29,172 8 Fl Oz bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.

Original FDA data

Every field from FDA enforcement report D-0863-2020, exactly as published.

Show all FDA fields
City
Hawthorne
State
NY
Status
Terminated
Country
United States
Event ID
84916
Address
3 Skyline Dr
Code information
Lot# 327874, 327876, Exp Dec/2020
Postal code
10532-2174
Report date
Mar 4, 2020
Product type
Drugs
Recall number
D-0863-2020
Classification
Class I
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Product quantity
29,172 8 Fl Oz bottles
Termination date
Dec 11, 2023
Reason for recall
Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phenytoin Oral Suspension USP, 125 mg/5 mL potency, 8 fl oz (237 mL) Rx Only Mfd. by: Taro Pharmaceuticals Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A. Inc. Hawthorne, NY 10532, NDC 51672-4069-1
Distribution pattern
Distributed Nationwide in the USA.
Recall initiation date
Feb 7, 2020
Initial firm notification
Letter
Center classification date
Mar 2, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0863-2020, published Mar 4, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls